BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15308115)

  • 1. Gene expression profiling in peripheral blood mononuclear cells from lupus patients with active and inactive disease.
    Rus V; Chen H; Zernetkina V; Magder LS; Mathai S; Hochberg MC; Via CS
    Clin Immunol; 2004 Sep; 112(3):231-4. PubMed ID: 15308115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared and unique gene expression in systemic lupus erythematosus depending on disease activity.
    Sandrin-Garcia P; Junta CM; Fachin AL; Mello SS; Baião AM; Rassi DM; Ferreira MC; Trevisan GL; Sakamoto-Hojo ET; Louzada-Júnior P; Passos GA; Donadi EA
    Ann N Y Acad Sci; 2009 Sep; 1173():493-500. PubMed ID: 19758191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP
    Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array.
    Rus V; Atamas SP; Shustova V; Luzina IG; Selaru F; Magder LS; Via CS
    Clin Immunol; 2002 Mar; 102(3):283-90. PubMed ID: 11890715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferon-inducible genes lymphocyte antigen 6 complex E and tetratricopeptide repeats 1 are correlated with clinical features of patients with systemic lupus erythematosus].
    Tang JP; Gu YY; Shen N; Ye S; Qian J; Hua J; Chen XG; Chen SL; Bao CD; Wang Y; Zhang W
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1157-60. PubMed ID: 15387975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus.
    Nikpour M; Dempsey AA; Urowitz MB; Gladman DD; Barnes DA
    Ann Rheum Dis; 2008 Aug; 67(8):1069-75. PubMed ID: 18063674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene expression profiling of peripheral leukocytes from patients with systemic lupus erythematosus using oligonucleotide DNA microarray].
    Wu YS; Fan RQ; Chen DC; Xuan GW
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):929-34. PubMed ID: 16109543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray.
    Han GM; Chen SL; Shen N; Ye S; Bao CD; Gu YY
    Genes Immun; 2003 Apr; 4(3):177-86. PubMed ID: 12700592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients.
    Dai Y; Huang YS; Tang M; Lv TY; Hu CX; Tan YH; Xu ZM; Yin YB
    Lupus; 2007; 16(12):939-46. PubMed ID: 18042587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased spontaneous but decreased mitogen-stimulated expression and excretion of interleukin 18 by mononuclear cells in patients with active systemic lupus erythematosus.
    Lee HT; Chen WS; Sun KH; Chou CT; Tsai CY
    J Rheumatol; 2009 Sep; 36(9):1910-6. PubMed ID: 19605669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
    Her M; Kim D; Oh M; Jeong H; Choi I
    Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenomena and pathological significances of the methylated p16 promotor in DNA derived from plasma and blood cells of patients with systemic lupus erythematosus].
    Li AS; Li YM; Yang AZ; Yao X; Chen ZQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):675-81. PubMed ID: 17121230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients.
    Ishii T; Onda H; Tanigawa A; Ohshima S; Fujiwara H; Mima T; Katada Y; Deguchi H; Suemura M; Miyake T; Miyatake K; Kawase I; Zhao H; Tomiyama Y; Saeki Y; Nojima H
    DNA Res; 2005; 12(6):429-39. PubMed ID: 16769699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
    Ripley BJ; Rahman MA; Isenberg DA; Latchman DS
    Arthritis Rheum; 2005 Apr; 52(4):1171-9. PubMed ID: 15818685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus.
    Qing X; Putterman C
    Autoimmun Rev; 2004 Nov; 3(7-8):505-9. PubMed ID: 15546798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus.
    Kurosaka D; Yasuda J; Yoshida K; Yoneda A; Yasuda C; Kingetsu I; Toyokawa Y; Yokoyama T; Saito S; Yamada A
    J Rheumatol; 2006 Jun; 33(6):1102-7. PubMed ID: 16755657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity.
    Sodsai P; Hirankarn N; Avihingsanon Y; Palaga T
    Lupus; 2008 Jul; 17(7):645-53. PubMed ID: 18625637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.